Drug profile · INN
pandemic influenza vaccine (h5n1) (live attenuated, nasal)
PANDEMIC INFLUENZA VACCINE H5N1 ASTRAZENECA (PREVIOUSLY PANDEMIC INFLUENZA VACCINE H5N1 MEDIMMUNE)
pandemic influenza vaccine (h5n1) (live attenuated, nasal) (PANDEMIC INFLUENZA VACCINE H5N1 ASTRAZENECA (PREVIOUSLY PANDEMIC INFLUENZA VACCINE H5N1 MEDIMMUNE)) is a biological vaccine - induces immune response.
Drug details — pandemic influenza vaccine (h5n1) (live attenuated, nasal)
- Class
- Antiinfectives for systemic use (J07)
- Route
- —
- Patents
- 0
- Programs
- 22
- Data quality
- 0.83
Quick answer
pandemic influenza vaccine (h5n1) (live attenuated, nasal) (PANDEMIC INFLUENZA VACCINE H5N1 ASTRAZENECA (PREVIOUSLY PANDEMIC INFLUENZA VACCINE H5N1 MEDIMMUNE)) is a biological vaccine - induces immune response.
Key facts
Mechanism of action
Biological vaccine - induces immune response
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is pandemic influenza vaccine (h5n1) (live attenuated, nasal)?
pandemic influenza vaccine (h5n1) (live attenuated, nasal) (PANDEMIC INFLUENZA VACCINE H5N1 ASTRAZENECA (PREVIOUSLY PANDEMIC INFLUENZA VACCINE H5N1 MEDIMMUNE)) is a biological vaccine - induces immune response.
What is the brand name for pandemic influenza vaccine (h5n1) (live attenuated, nasal)?
PANDEMIC INFLUENZA VACCINE H5N1 ASTRAZENECA (PREVIOUSLY PANDEMIC INFLUENZA VACCINE H5N1 MEDIMMUNE) is a marketed brand name for pandemic influenza vaccine (h5n1) (live attenuated, nasal). Check FDA Drugs@FDA for the current US label holder and prescribing information.